Paroxetine vs Topiramate: side-by-side comparison
Paroxetine (Selective serotonin reuptake inhibitor (SSRI)) and Topiramate (Antiepileptic (sulfamate-substituted monosaccharide)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Paroxetine | Topiramate |
|---|---|---|
| Therapeutic class | Selective serotonin reuptake inhibitor (SSRI) | Antiepileptic (sulfamate-substituted monosaccharide) |
| CAS | 61869-08-7 | 97240-79-4 |
| ATC | N06AB05 | N03AX11 |
| Molecular weight | 329.37 g/mol | 339.36 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Paroxetine and Topiramate share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Paroxetine acts by a different mechanism than Topiramate, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Paroxetine: Paroxetine selectively inhibits the serotonin reuptake transporter, increasing serotonin availability at the synapse. Topiramate: Topiramate is a sulfamate-substituted monosaccharide with multiple mechanisms of action: blockade of voltage-gated sodium channels, enhancement of gamma-aminobutyric acid (GABA) activity at non-benzodiazepine GABA-A rece…
Indications compared
Paroxetine: Paroxetine is approved for major depressive disorder, generalised anxiety disorder, social anxiety disorder, panic disorder, obsessive-compulsive disorder and post-traumatic stress disorder, with regional variation. Topiramate: Topiramate is approved in adults and children for the treatment of partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome (as adjunctive or monotherapy depe…
Safety profile
Paroxetine: Common adverse effects include nausea, sexual dysfunction (more pronounced than with most SSRIs), weight gain, sleep disturbance, fatigue and anticholinergic symptoms. Topiramate: Common adverse effects include paraesthesia, fatigue, dizziness, anorexia and weight loss, and cognitive symptoms (word-finding difficulties, concentration problems).
Frequently asked questions
Is Paroxetine better than Topiramate? ▾
Paroxetine and Topiramate are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Paroxetine and Topiramate be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Paroxetine
Products with Topiramate
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.